Protein and non-protein biomarkers in melanoma: a critical update (Q38050990)

27 August 2017

title

Protein and non-protein biomarkers in melanoma: a critical update (English)

1 reference

27 August 2017

0 references

Jens Pietzsch

3

0 references

author name string

Nadine Tandler

series ordinal

1

1 reference

27 August 2017

Birgit Mosch

series ordinal

2

1 reference

27 August 2017

publication date

6 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

43

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

2203-2230

1 reference

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Diagnostic and Prognostic Role of Galectin 3 Expression in Cutaneous Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100P: a novel therapeutic target for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100P promotes pancreatic cancer growth, survival, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III-IV malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Genome-wide association study identifies three new melanoma susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100P, a novel Ca2+ -binding protein from human placenta. cDNA cloning, recombinant protein expression and Ca2+ binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

COX-2 expression in malignant melanoma: a novel prognostic marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Ultraviolet radiation damages self noncoding RNA and is detected by TLR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Detection of melanoma relapse: first comparative analysis on imaging techniques versus S100 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Genome-wide association study identifies three loci associated with melanoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Novel biomarkers in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Prognostic value of serial blood S100B determinations in stage IIB–III melanoma patients: A corollary study to EORTC trial 18952

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Serological markers for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Association of galectin-3 expression with melanoma progression and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Highly sensitive detection of melanoma based on serum proteomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

T-cell recognition of melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Survivin: a dual player in healthy and diseased skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Intracellular Ca2+ and Zn2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Staging and prognosis of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100B's double life: intracellular regulator and extracellular signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Mechanism of RAF isoform switching induced by oncogenic RAS in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

CEACAM1 enhances invasion and migration of melanocytic and melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Up-to-date results on survival of patients with melanoma in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Prognostic value of [18F]-fluoro-deoxy-glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Newly identified tumor antigens as promising cancer vaccine targets for malignant melanoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Proteome serological determination of tumor-associated antigens in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Serum microRNAs as biomarkers for recurrence in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100A6 expression in fibrohistiocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Transcriptional regulation and functional implication of S100P in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Childhood exposure to ultraviolet radiation and harmful skin effects: epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The RTK/RAS/BRAF/PI3K pathways in melanoma: biology, small molecule inhibitors, and potential applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Frequent mutation of BAP1 in metastasizing uveal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The metastasis associated protein S100A4: role in tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Survival from common and rare cancers in Germany in the early 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The secreted form of a melanocyte membrane-bound glycoprotein (Pmel17/gp100) is released by ectodomain shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

A landscape of driver mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Apoptosis and melanoma: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Identification of proteins secreted by human osteoblastic cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Serum YKL-40, a new prognostic biomarker in cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Spontaneous regression of metastases from melanoma: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Ultraviolet radiation and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Quantitative measurement of circulating lymphoid-specific helicase (HELLS) gene transcript: a potential serum biomarker for melanoma metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Plasma markers for identifying patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Radiosynthesis of a ¹⁸F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Tumor cell and circulating markers in melanoma: diagnosis, prognosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The current status of S-100B as a biomarker in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S-100B concentrations predict disease-free survival in stage III melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Use of S-100B to evaluate therapy effects during bevacizumab induction treatment in AJCC stage III melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The WNT/Beta-catenin pathway in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Estrogen regulation of TRPM8 expression in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100A6 - new facts and features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Ocular melanoma: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

RAGE and RAGE ligands in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Isolation of tumorigenic circulating melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Brain-metastatic melanoma: a neurotrophic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

A new era in the treatment of melanoma: from biology to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100A13 is a new angiogenic marker in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Systematic identification of human melanoma antigens using serial analysis of gene expression (SAGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Molecular markers of circulating melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The S100B protein in biological fluids: more than a lifelong biomarker of brain distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The prognostic value of serum S100B in patients with cutaneous melanoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

A soluble protein characteristic of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Old and new serological biomarkers in melanoma: where we are in 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The KISS1 metastasis suppressor: mechanistic insights and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Prostaglandin production by melanocytic cells and the effect of alpha-melanocyte stimulating hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Are all melanomas dangerous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Transcriptional regulation of metastasis-related genes in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Circulating serologic and molecular biomarkers in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Serum markers of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Expression patterns of S100 proteins in melanocytes and melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Integrins: versatile receptors controlling melanocyte adhesion, migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Cathepsin K in melanoma invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

MMP2 expression is a prognostic marker for primary melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Melanoma-associated antigen genes – An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Comparison between three molecular methods for detection of blood melanoma tyrosinase mRNA. Correlation with melanoma stages and S100B, LDH, NSE biochemical markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

CEACAM1 in malignant melanoma: a diagnostic and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Cell-free nucleic acids as biomarkers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Uveal melanoma: trends in incidence, treatment, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Immunity to melanoma antigens: from self-tolerance to immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Characterization of the Melanoma miRNAome by Deep Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Neurotrophins and their receptors stimulate melanoma cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100B: a multifunctional role in cardiovascular pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

gp100 mRNA is more sensitive than tyrosinase mRNA for RT-PCR amplification to detect circulating melanoma cells in peripheral blood of melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Melanocytes in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Mutations in GNA11 in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

A new standardized absolute quantitative RT-PCR method for detection of tyrosinase mRNAs in melanoma patients: technical and operative instructions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

SPECT/CT for sentinel lymph node mapping in head and neck melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The 'epidemic' of melanoma between under- and overdiagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Prognostic factors for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100A2 in cancerogenesis: a friend or a foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Genetic and epigenetic alterations of the APC gene in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Genome-wide associations studies for melanoma and nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

IL-8 and cathepsin B as melanoma serum biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Osteopontin expression correlates with melanoma invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Osteopontin expression in plasma of melanoma patients and in melanocytic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Malignant Melanoma–a Genetic Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

A High-Throughput Study in Melanoma Identifies Epithelial-Mesenchymal Transition as a Major Determinant of Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Uveal Melanoma andBRCA1/BRCA2Genes: A Relationship That Needs Further Investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1409-5

10.1007/S00726-012-1409-5

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference